{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:59:20Z","timestamp":1793473160296,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acting to prevent the next fracture after a sentinel fracture is support by the evidence base and brings benefits for patients, clinicians and healthcare systems. However, more patients after a fragility fracture remain untreated and vulnerable to future potentially life-changing fractures. Fracture liaison services (FLS) are models of care that can close this care gap.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A narrative review of the key evidence for the efficacy and effectiveness of FLS was performed<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There are few randomised control trials of FLSs and none with fracture as the primary outcome. Several observational studies have also demonstrated reductions in fracture, but most were limited by potential bias. Several studies have highlighted that not every FLS is automatically effective.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Further research should focus on implementing effective FLS using published standards and only then exploring impacts on patient outcomes such as refracture rates.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40520-021-01844-9","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T09:11:28Z","timestamp":1622193088000},"page":"2061-2067","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Efficacy and efficiency of fracture liaison services to reduce the risk of recurrent osteoporotic fractures"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-0048","authenticated-orcid":false,"given":"M. K.","family":"Javaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"key":"1844_CR1","unstructured":"Kanis J, McCloskey E, Harvey NC et al (2018) Broken bones, broken lives: a roadmap to solve the fragility fracture crisis in Europe. Broken bones, broken lives: http:\/\/share.iofbonehealth.org\/EU-6-Material\/Reports\/IOF%20Report_EU.pdf: International Osteoporosis Foundation."},{"key":"1844_CR2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","volume":"15","author":"CM Klotzbuecher","year":"2000","unstructured":"Klotzbuecher CM, Ross PD, Landsman PB et al (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721\u2013739","journal-title":"J Bone Miner Res"},{"key":"1844_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375\u2013382","journal-title":"Bone"},{"key":"1844_CR4","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s00198-011-1642-x","volume":"22","author":"D Marsh","year":"2011","unstructured":"Marsh D, Akesson K, Beaton DE et al (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22:2051\u20132065","journal-title":"Osteoporos Int"},{"key":"1844_CR5","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00198-015-3098-x","volume":"26","author":"C Klop","year":"2015","unstructured":"Klop C, Gibson-Smith D, Elders PJ et al (2015) Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000\u20132010. Osteoporos Int 26:1919\u20131928","journal-title":"Osteoporos Int"},{"key":"1844_CR6","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00198-020-05358-4","volume":"31","author":"MK Skj\u00f8dt","year":"2020","unstructured":"Skj\u00f8dt MK, Khalid S, Ernst M et al (2020) Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom. Osteoporos Int 31:1535\u20131544","journal-title":"Osteoporos Int"},{"key":"1844_CR7","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00198-013-2348-z","volume":"24","author":"K Akesson","year":"2013","unstructured":"Akesson K, Marsh D, Mitchell PJ et al (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135\u20132152","journal-title":"Osteoporos Int"},{"key":"1844_CR8","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s00198-015-3192-0","volume":"26","author":"MK Javaid","year":"2015","unstructured":"Javaid MK, Kyer C, Mitchell PJ et al (2015) Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF capture the fracture(R) best practice framework tool. Osteoporos Int 26:2573\u20132578","journal-title":"Osteoporos Int"},{"key":"1844_CR9","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1002\/jbmr.1698","volume":"27","author":"JA Eisman","year":"2012","unstructured":"Eisman JA, Bogoch ER, Dell R et al (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27:2039\u20132046. https:\/\/doi.org\/10.1002\/jbmr.1698","journal-title":"J Bone Miner Res"},{"key":"1844_CR10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/annrheumdis-2016-210289","volume":"76","author":"WF Lems","year":"2017","unstructured":"Lems WF, Dreinhofer KE, Bischoff-Ferrari H et al (2017) EULAR\/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures. Ann Rheum Dis 76:802\u2013810","journal-title":"Ann Rheum Dis"},{"key":"1844_CR11","first-page":"405","volume-title":"Primer in the metabolic bone diseases and disorders of mineral metabolism","author":"P Geusens","year":"2019","unstructured":"Geusens P, Eisman JA, Singer A et al (2019) Fracture liaison service. In: Bilezikian JP (ed) Primer in the metabolic bone diseases and disorders of mineral metabolism. John Wiley & Sons INc, pp 405\u2013411"},{"key":"1844_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40520-018-1109-4","volume":"31","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R et al (2019) Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Aging Clin Exp Res 31:15\u201317","journal-title":"Aging Clin Exp Res"},{"key":"1844_CR13","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s40520-020-01574-4","volume":"32","author":"A De Vincentis","year":"2020","unstructured":"De Vincentis A, Behr AU, Bellelli G et al (2020) Management of hip fracture in the older people: rationale and design of the Italian consensus on the orthogeriatric co-management. Aging Clin Exp Res 32:1393\u20131399","journal-title":"Aging Clin Exp Res"},{"key":"1844_CR14","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s40520-018-1054-2","volume":"31","author":"I Sanli","year":"2019","unstructured":"Sanli I, van Helden SH, Ten Broeke RHM et al (2019) The role of the fracture liaison service (FLS) in subsequent fracture prevention in the extreme elderly. Aging Clin Exp Res 31:1105\u20131111","journal-title":"Aging Clin Exp Res"},{"key":"1844_CR15","unstructured":"McLellan A, Reid DM, Forbes K, Reid R, Campbell C, Gregori A, et al. Effectiveness of Strategies for the Secondary Prevention of Osteoporotic Fractures in Scotland: CEPS: 99\/03. NHS Quality Improvement Scotland 2004. http:\/\/www.healthcareimprovementscotland.org\/his\/idoc.ashx?docid=ef9ef57b-be5a-4677-9e26-ff941bd01dc1&version=-1"},{"key":"1844_CR16","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.berh.2005.07.001","volume":"19","author":"SJ Gallacher","year":"2005","unstructured":"Gallacher SJ (2005) Setting up an osteoporosis fracture liaison service: background and potential outcomes. Best Pract Res Clin Rheumatol 19:1081\u20131094","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1844_CR17","unstructured":"Gallacher S, Alexander S, Beswetherick N, Carr W, Durber A, Gittoes N et al (2019) Effective secondary prevention of fragility fractures: clinical standards for fracture liaison services. Royal Osteoporosis Society. https:\/\/theros.org.uk\/media\/1eubz33w\/ros-clinical-standards-for-fracture-liaison-services-august-2019.pdf"},{"key":"1844_CR18","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture intervention trial research group. Lancet 348:1535\u20131541","journal-title":"Lancet"},{"key":"1844_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s001980050010","volume":"11","author":"J Reginster","year":"2000","unstructured":"Reginster J, Minne HW, Sorensen OH et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with risedronate therapy (VERT) study group. Osteoporos Int 11:83\u201391","journal-title":"Osteoporos Int"},{"key":"1844_CR20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1056\/NEJMoa022436","volume":"350","author":"PJ Meunier","year":"2004","unstructured":"Meunier PJ, Roux C, Seeman E et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459\u2013468","journal-title":"N Engl J Med"},{"key":"1844_CR21","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1359\/JBMR.040325","volume":"19","author":"CH Chesnut 3rd","year":"2004","unstructured":"Chesnut CH 3rd, Skag A, Christiansen C et al (2004) Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19:1241\u20131249","journal-title":"J Bone Miner Res"},{"key":"1844_CR22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765","journal-title":"N Engl J Med"},{"key":"1844_CR23","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809\u20131822","journal-title":"N Engl J Med"},{"key":"1844_CR24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jama.2016.11136","volume":"316","author":"PD Miller","year":"2016","unstructured":"Miller PD, Hattersley G, Riis BJ et al (2016) Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA 316:722\u2013733","journal-title":"JAMA"},{"key":"1844_CR25","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375:1532\u20131543","journal-title":"N Engl J Med"},{"key":"1844_CR26","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/jbmr.2882","volume":"31","author":"S Hawley","year":"2016","unstructured":"Hawley S, Leal J, Delmestri A et al (2016) Anti-osteoporosis medication prescriptions and incidence of subsequent fracture among primary hip fracture patients in England and wales: an interrupted time-series analysis. J Bone Miner Res 31:2008-2015","journal-title":"J Bone Miner Res"},{"key":"1844_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00198-012-2068-9","volume":"24","author":"N Freemantle","year":"2013","unstructured":"Freemantle N, Cooper C, Diez-Perez A et al (2013) Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis. Osteoporos Int 24:209\u2013217","journal-title":"Osteoporos Int"},{"key":"1844_CR28","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s00198-019-05274-2","volume":"31","author":"WD Leslie","year":"2020","unstructured":"Leslie WD, Schousboe JT, Morin SN et al (2020) Fracture risk following high-trauma versus low-trauma fracture: a registry-based cohort study. Osteoporos Int 31:1059\u20131067","journal-title":"Osteoporos Int"},{"key":"1844_CR29","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1001\/jama.298.20.2381","volume":"298","author":"DC Mackey","year":"2007","unstructured":"Mackey DC, Lui LY, Cawthon PM et al (2007) High-trauma fractures and low bone mineral density in older women and men. JAMA 298:2381\u20132388","journal-title":"JAMA"},{"key":"1844_CR30","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1002\/jbmr.446","volume":"26","author":"DC Mackey","year":"2011","unstructured":"Mackey DC, Black DM, Bauer DC et al (2011) Effects of antiresorptive treatment on nonvertebral fracture outcomes. J Bone Miner Res 26:2411\u20132418","journal-title":"J Bone Miner Res"},{"key":"1844_CR31","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00198-017-3976-5","volume":"28","author":"C Roux","year":"2017","unstructured":"Roux C, Briot K (2017) Imminent fracture risk. Osteoporos Int 28:1765\u20131769","journal-title":"Osteoporos Int"},{"key":"1844_CR32","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00198-018-4502-0","volume":"29","author":"JA Kanis","year":"2018","unstructured":"Kanis JA, Johansson H, Oden A et al (2018) Characteristics of recurrent fractures. Osteoporos Int 29:1747\u20131757","journal-title":"Osteoporos Int"},{"key":"1844_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11657-019-0569-2","volume":"14","author":"R Pinedo-Villanueva","year":"2019","unstructured":"Pinedo-Villanueva R, Charokopou M et al (2019) Imminent fracture risk assessments in the UK FLS setting: implications and challenges. Arch Osteoporos 14:12","journal-title":"Arch Osteoporos"},{"key":"1844_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0140-6736(17)32137-2","volume":"391","author":"DL Kendler","year":"2018","unstructured":"Kendler DL, Marin F, Zerbini CAF et al (2018) Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet\u00a0 391:230\u2013240","journal-title":"Lancet"},{"key":"1844_CR35","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML et al (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377:1417\u20131427","journal-title":"N Engl J Med"},{"key":"1844_CR36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00774-012-0349-1","volume":"30","author":"CA Inderjeeth","year":"2012","unstructured":"Inderjeeth CA, Chan K, Kwan K et al (2012) Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments. J Bone Miner Metab 30:493\u2013503","journal-title":"J Bone Miner Metab"},{"key":"1844_CR37","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1503\/cmaj.070981","volume":"178","author":"SR Majumdar","year":"2008","unstructured":"Majumdar SR, Johnson JA, McAlister FA et al (2008) Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ 178:569\u2013575","journal-title":"CMAJ"},{"key":"1844_CR38","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1002\/jbmr.3557","volume":"33","author":"SR Majumdar","year":"2018","unstructured":"Majumdar SR, McAlister FA, Johnson JA et al (2018) Comparing strategies targeting osteoporosis to prevent fractures after an upper extremity fracture (C-STOP Trial): a randomized controlled trial. J Bone Miner Res 33:2114","journal-title":"J Bone Miner Res"},{"key":"1844_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00198-018-4702-7","volume":"30","author":"FA McAlister","year":"2019","unstructured":"McAlister FA, Ye C, Beaupre LA et al (2019) Adherence to osteoporosis therapy after an upper extremity fracture: a pre-specified substudy of the C-STOP randomized controlled trial. Osteoporos Int 30:127\u2013134","journal-title":"Osteoporos Int"},{"key":"1844_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2106\/JBJS.H.00628","volume":"90","author":"R Dell","year":"2008","unstructured":"Dell R, Greene D, Schelkun SR et al (2008) Osteoporosis disease management: the role of the orthopaedic surgeon. J Bone Joint Surg Am 90:88\u2013194","journal-title":"J Bone Joint Surg Am"},{"key":"1844_CR41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/ageing\/afv204","volume":"45","author":"S Hawley","year":"2016","unstructured":"Hawley S, Javaid MK, Prieto-Alhambra D et al (2016) Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study. Age Ageing 45:236\u2013242","journal-title":"Age Ageing"},{"key":"1844_CR42","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s00198-015-3452-z","volume":"27","author":"S Drew","year":"2016","unstructured":"Drew S, Judge A, Cooper C et al (2016) Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery. Osteoporos Int 27:1719","journal-title":"Osteoporos Int"},{"key":"1844_CR43","doi-asserted-by":"publisher","first-page":"e9012","DOI":"10.1097\/MD.0000000000009012","volume":"96","author":"DE Beaton","year":"2017","unstructured":"Beaton DE, Mamdani M, Zheng H et al (2017) Improvements in osteoporosis testing and care are found following the wide scale implementation of the Ontario fracture clinic screening program: an interrupted time series analysis. Medicine 96:e9012","journal-title":"Medicine"},{"key":"1844_CR44","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/jbmr.3990","volume":"35","author":"KF Axelsson","year":"2020","unstructured":"Axelsson KF, Johansson H, Lundh D et al (2020) Association between recurrent fracture risk and implementation of fracture liaison services in four Swedish hospitals: a cohort study. J Bone Miner Res 35:1216\u20131223","journal-title":"J Bone Miner Res"},{"key":"1844_CR45","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00198-011-1534-0","volume":"22","author":"AR McLellan","year":"2011","unstructured":"McLellan AR, Wolowacz SE, Zimovetz EA et al (2011) Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int 22:2083\u20132098","journal-title":"Osteoporos Int"},{"key":"1844_CR46","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2106\/JBJS.G.00980","volume":"90","author":"B Sander","year":"2008","unstructured":"Sander B, Elliot-Gibson V, Beaton DE, Bogoch ER, Maetzel A (2008) A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. J Bone Joint Surg Am 90:1197\u20131205","journal-title":"J Bone Joint Surg Am"},{"key":"1844_CR47","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00198-010-1477-x","volume":"22","author":"A Lih","year":"2011","unstructured":"Lih A, Nandapalan H, Kim M et al (2011) Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4 year prospective controlled study. Osteoporos Int 22:849\u2013858","journal-title":"Osteoporos Int"},{"key":"1844_CR48","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00198-015-3443-0","volume":"27","author":"A Nakayama","year":"2015","unstructured":"Nakayama A, Major G, Holliday E et al (2015) Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate. Osteoporos Int 27:873","journal-title":"Osteoporos Int"},{"key":"1844_CR49","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.2106\/JBJS.L.00223","volume":"96","author":"KM Huntjens","year":"2014","unstructured":"Huntjens KM, van Geel TA, van den Bergh JP et al (2014) Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality. J Bone Joint Surg Am 96:e29","journal-title":"J Bone Joint Surg Am"},{"key":"1844_CR50","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00198-011-1544-y","volume":"22","author":"JE Sale","year":"2011","unstructured":"Sale JE, Beaton D, Posen J et al (2011) Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int 22:2067\u20132082","journal-title":"Osteoporos Int"},{"key":"1844_CR51","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00198-012-2090-y","volume":"24","author":"K Ganda","year":"2013","unstructured":"Ganda K, Puech M, Chen JS et al (2013) Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int 24:393\u2013406","journal-title":"Osteoporos Int"},{"key":"1844_CR52","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00198-011-1712-0","volume":"22","author":"R Dell","year":"2011","unstructured":"Dell R (2011) Fracture prevention in Kaiser Permanente Southern California. Osteoporos Int 22:457\u2013460","journal-title":"Osteoporos Int"},{"key":"1844_CR53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/1756-185X.12101","volume":"17","author":"J Van der Kallen","year":"2014","unstructured":"Van der Kallen J, Giles M, Cooper K et al (2014) A fracture prevention service reduces further fractures two years after incident minimal trauma fracture. Int J Rheum Dis 17:195\u2013203","journal-title":"Int J Rheum Dis"},{"key":"1844_CR54","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00198-017-4370-z","volume":"29","author":"CH Wu","year":"2018","unstructured":"Wu CH, Chen CH, Chen PH et al (2018) Identifying characteristics of an effective fracture liaison service: systematic literature review. Osteoporos Int 29:1023","journal-title":"Osteoporos Int"},{"key":"1844_CR55","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Colon-Emeric CS, Magaziner JS et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799\u20131809","journal-title":"N Engl J Med"},{"key":"1844_CR56","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1136\/bmj.312.7031.619","volume":"312","author":"DM Berwick","year":"1996","unstructured":"Berwick DM (1996) A primer on leading the improvement of systems. BMJ 312:619\u2013622","journal-title":"BMJ"},{"key":"1844_CR57","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00198-019-05016-4","volume":"30","author":"P van den Berg","year":"2019","unstructured":"van den Berg P, van Haard PMM, Geusens PP et al (2019) Challenges and opportunities to improve fracture liaison service attendance: fracture registration and patient characteristics and motivations. Osteoporos Int 30:1597\u20131606","journal-title":"Osteoporos Int"},{"key":"1844_CR58","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00198-013-2348-z","volume":"24","author":"K Akesson","year":"2013","unstructured":"Akesson K, Marsh D, Mitchell PJ et al (2013) Capture the fracture: a global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135","journal-title":"Osteoporos Int"},{"key":"1844_CR59","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00198-020-05377-1","volume":"31","author":"MK Javaid","year":"2020","unstructured":"Javaid MK, Sami A, Lems W et al (2020) A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network. Osteoporos Int 31:1193","journal-title":"Osteoporos Int"},{"key":"1844_CR60","first-page":"1","volume-title":"FLS forward: identifying high-quality care in the NHS for secondary fracture prevention","author":"C Boulton","year":"2017","unstructured":"Boulton C, Gallagher C, Rai S et al (2017) Fracture liaison service database (FLS-DB) clinical audit. In: Programme FaFFA (ed) FLS forward: identifying high-quality care in the NHS for secondary fracture prevention. Royal Collge of Physicians, London, pp 1\u201370"},{"key":"1844_CR61","volume-title":"Fracture liaison service database annual report december 2018: achieving effective service delivery by fracture liaison services London","author":"MK Javaid","year":"2018","unstructured":"Javaid MK, Vasilakis N, Dickinson R et al (2018) Fracture liaison service database annual report december 2018: achieving effective service delivery by fracture liaison services London. Royal College of Physicians"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-021-01844-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-021-01844-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-021-01844-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T09:39:29Z","timestamp":1627033169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-021-01844-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1844"],"URL":"https:\/\/doi.org\/10.1007\/s40520-021-01844-9","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,28]]},"assertion":[{"value":"29 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Unrelated to this piece of work, Dr Javaid has received over the last 5\u00a0years reimbursement for advisory boards, consultancy and speaker fees from Amgen, Consilient Health, Kyowa Kirin Hakin, UCB and Abbvie.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study does not contain any studies with animals performed by any of the authors and complies with guidelines for human studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}